Endothelin as a causative factor of blunted volume reflex in diabetic rats

British Journal of Pharmacology

Volumn 138, Issue 8, 2003, Pages 1403-1410

  Wongmekiat, Orawan ^a   Johns, Edward J ^b  

^a Faculty of Medicine Chiang Mai University   (Thailand)

^b UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Diabetes mellitus; Endothelin; Endothelin antagonists; Renal nerves; Volume expansion

Indexed keywords

3 (2 CARBOXYMETHOXY 4 METHOXYPHENYL) 1 (3,4 METHYLENEDIOXYPHENYL) 5 PROPOXY 2 INDANCARBOXYLIC ACID; ENDOTHELIN; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR ANTAGONIST; UK 350926; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY FLUID; CONTROLLED STUDY; DIABETES MELLITUS; EXTRACELLULAR SPACE; FLUID BALANCE; KIDNEY DENERVATION; KIDNEY INNERVATION; KIDNEY NERVE; MALE; MICTURITION; NONHUMAN; PRIORITY JOURNAL; RAT; SODIUM EXCRETION; STREPTOZOCIN DIABETES; SYMPATHETIC NERVE;

ANIMALS; BLOOD VOLUME; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELINS; INDANS; KIDNEY; MALE; RATS; RATS, WISTAR; RECEPTORS, ENDOTHELIN; REFLEX;

EID: 0038291701     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705133     Document Type: Article

References (25)

1. BERETTA-PICCOLI, C., ELSHATER-ZANETTI, F., SHAW, S. & CUSI, D. (1994). Acute sodium loading in patients with uncomplicated diabetes mellitus: renal and hormonal effects. Clin. Sci., 86, 383-390.
2. BOJESEN, E. (1952). A method for determination of inulin in plasma and urine. Acta Med. Scand., 142, 275-282.
3. DOUGLAS, S.A., GELLAI, M., EZEKIEL, M., FEUERSTEIN, G.Z., ELLIOTT, J.D. & OHLSTEIN, E.H. (1995). Antihypertensive actions of the novel nonpeptide endothelin receptor antagonist SB209670. Hypertension, 25, 818-822.
4. GARDINER, S.M., MARCH, J.E., KEMP, P.A., MULLINS, J.J. & BENNETT, T. (1995). Haemodynamic effects of losartan and the endothelin antagonist, SB209670, in conscious, transgenic ((mRen-2) 27), hypertensive rats. Br. J. Pharmacol., 116, 2237-2244.
5. GELLAI, M., DE WOLF, R., PULLEN, M. & NAMBI, P. (1994). Distribution and functional role of renal ET receptor subtypes in normotensive and hypertensive rats. Kidney Int., 46, 1287-1294.
6. HOCHER, B., LUN, A., PRIEM, F., NEUMAYER, H. & RASCHACK, M. (1998). Renal endothelin system in diabetes: comparison of angiotensin-converting enzyme inhibitor and endothelin-A antagonism. J. Cardiovasc. Pharmacol., 31(suppl 1), S492-S495.
7. HUANG, C.L., HUANG, C.H., HESTIN, D., DENT, P.C, BARCLAY, P., COLLIS, M. & JOHNS, E.J. (2002). The effect of endothelin antagonists on renal ischaemia - reperfusion injury and the development of acute renal failure in the rat. Nephrol. Dial. Transplant., 17, 1-8.
8. KOHAN, D.E. (1997). Endothelins in the normal and diseased kidney. Am. J. Kidney Dis., 29, 2-26.
9. KOIDE, H., NAKAMURA, T., EBIHARA, I. & FUKUI, M. (1995). Endothelins in diabetic kidneys. Kidney Int., 48, S45-S49.
10. LERMAN, A., HILDEBRAND, F.L., AARHUS, L.L. & BURNETT, J.C. (1991). Endothelin has biological actions at pathophysiological concentrations. Circulation, 83, 1808-1814.
11. MAKINO, A. & KAMATA, K. (1998). Elevated plasma endothelin-1 level in streptozotocin-induced diabetic rats and responsiveness of the mesenteric arterial bed to endothelin-1. Br. J. Pharmacol., 123(6), 1065-1072.
12. MORABITO, E., CORSICO, N., SERAFINI, S. & MARTELLI, E.A. (1994). Elevated urinary excretion of endothelins in streptozotocin-diabetic rats. Life Sci., 54, PL197-PL200.
13. PATEL, K.P. (1997). Volume reflex in diabetes. Cardiovasc. Res., 34, 81-90.
14. PATEL, K.P. & ZHANG, P.L. (1989). Reduced renal responses to volume expansion in streptozotocin-induced diabetic rats. Am. J. Physiol., 257, R672-R679.
15. PATEL, K.P. & ZHANG, P.L. (1994). Reduced renal sympathoinhibition in response to acute volume expansion in diabetic rats. Am. J. Physiol., 267, H960-H966.
16. PATEL, K.P., ZHANG, P.L., ZEIGLER, D.W. & KAUKER, M.L. (1997). Renal response to volume expansion in streptozotocin-induced diabetic rats: influence of calcium channel blockade. Diabetes Res. Clin. Prac., 35, 69-74.
17. QIU, C., SAMSELL, L. & BAYLIS, C. (1995). Actions of endogenous endothelin on glomerular hemodynamics in the rat. Am. J. Physiol., 269, R469-R473.
18. RUBANYI, G.M. & POLOKOFF, M.A. (1994). Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol. Rev., 46, 325-415.
19. SANDGAARD, N.C.F. & BIE, P. (1996). Natriuretic effect of nonpressor doses of endothelin-1 in conscious dog. J. Physiol., 494, 809-818.
20. SOWERS, J.R. & EPSTEIN, M. (1995). Diabetes mellitus and associated hypertension, vascular disease, and nephropathy. Hypertension, 26, 869-879.
21. TAKAGI, H., HISA, H. & SATOH, S. (1991). Effects of endothelin on adrenergic neurotransmission in the dog kidney. Eur. J. Pharmacol., 203, 291-294.
22. WONG-DUSTING, H.K., LA, M. & RAND, M.J. (1990). Mechanisms of the effects of endothelin on responses to noradrenaline and sympathetic nerve stimulation. Clin. Exp. Pharmacol. Physiol., 17, 269-273.
23. WONGMEKIAT, O. & JOHNS, E.J. (2001a). Contribution of endothelial nitric oxide synthase in the blunted renal responses to volume expansion in diabetic rats. Exp. Physiol., 86, 481-488.
24. WONGMEKIAT, O. & JOHNS, E.J. (2001b). Roles of endogenous endothelin on the volume regulatory mechanisms in anesthetized Wistar rats. Thai. J. Physiol. Sci., 14, 17-32.
25. ZHANG, P.L., PATEL, M.B. & PATEL, K.P. (1991). Renal responses to volume expansion and atrial-natriuretic factor in streptozotocin-induced diabetic rats. Diabetes Res. Clin. Prac., 14, 37-46.